Short description
Amylon Therapeutics is a biotechnology company that uses RNA Modulation Technology to target rare genetic disorders.
Description
Amylon Therapeutics is a biotechnology company that uses RNA Modulation Technology to target rare genetic disorders of the central nervous system (CNS). Our mission is to deliver on the potential of our technology by developing life-changing therapeutic solutions for patients with serious unmet medical need. We have high ambitions and want to change the way the world looks at neurological disorders. The enormous burden these diseases put on patients and their loved ones is unacceptable and something we strive to change every day. We believe that every patient deserves the hope for a brighter future. Our vision is to build a sustainable drug development platform in which the whole is bigger than the sum of its parts. This will allow us to focus on CNS diseases large and small and hopefully leave no patient untreated.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Leiden, Zuid-Holland, The Netherlands, Europe
Founded on
January 1, 2017
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Investors
Uh Ohhhh
Sign in for full access
Founders
Thomas de Vlaam